Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Celldex Therapeutics (CLDX)

Celldex Therapeutics (CLDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,683,052
  • Shares Outstanding, K 66,288
  • Annual Sales, $ 6,880 K
  • Annual Income, $ -141,430 K
  • EBIT $ -163 M
  • EBITDA $ -167 M
  • 60-Month Beta 1.60
  • Price/Sales 247.32
  • Price/Cash Flow N/A
  • Price/Book 2.09

Options Overview Details

View History
  • Implied Volatility 73.41% ( -0.32%)
  • Historical Volatility 56.81%
  • IV Percentile 90%
  • IV Rank 42.94%
  • IV High 116.13% on 09/17/24
  • IV Low 41.26% on 06/24/24
  • Put/Call Vol Ratio 0.59
  • Today's Volume 250
  • Volume Avg (30-Day) 580
  • Put/Call OI Ratio 0.45
  • Today's Open Interest 29,462
  • Open Int (30-Day) 31,444

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 12 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/24
See More
  • Average Estimate -0.69
  • Number of Estimates 6
  • High Estimate -0.61
  • Low Estimate -0.75
  • Prior Year -0.81
  • Growth Rate Est. (year over year) +14.81%

Price Performance

See More
Period Period Low Period High Performance
1-Month
24.43 +4.09%
on 11/05/24
31.66 -19.68%
on 10/14/24
-5.22 (-17.03%)
since 10/04/24
3-Month
24.43 +4.09%
on 11/05/24
47.00 -45.89%
on 09/25/24
-7.29 (-22.28%)
since 08/05/24
52-Week
24.43 +4.09%
on 11/05/24
53.18 -52.18%
on 03/04/24
-0.55 (-2.12%)
since 11/03/23

Most Recent Stories

More News
Celldex Announces Barzolvolimab Met All Primary and Secondary Endpoints with High Statistical Significance in Positive Phase 2 Study in Chronic Inducible Urticaria

CLDX : 25.43 (+0.16%)
Celldex Announces Upcoming Late Breaking Oral Presentation of 12 Week Results from Barzolvolimab Phase 2 Study in Chronic Inducible Urticaria at ACAAI 2024

CLDX : 25.43 (+0.16%)
Can This Growth Stock Deliver 135% Upside in 2025?

Positive clinical trial results have sparked hope for this biotech.

CLDX : 25.43 (+0.16%)
$SPX : 5,782.76 (+1.23%)
CLDX Stock Down Despite Upbeat Long-Term Data From Urticaria Study

Shares of Celldex Therapeutics CLDX lost 12.1% on Wednesday due to unsatisfactory 52-week safety data from a mid-stage study of its investigational candidate, barzolvolimab, which is being developed for...

CLDX : 25.43 (+0.16%)
KRYS : 174.41 (+2.08%)
FULC : 3.32 (+1.84%)
ANIP : 57.31 (+2.32%)
Celldex: Q2 Earnings Snapshot

Celldex: Q2 Earnings Snapshot

CLDX : 25.43 (+0.16%)
Stocks Post Modest Gains on Mixed US Economic Reports

The S&P 500 Index ($SPX ) (SPY ) today is up +0.17%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.24%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.03%. Stock indexes today are slightly...

$SPX : 5,782.76 (+1.23%)
SPY : 576.70 (+1.21%)
$DOWI : 42,221.88 (+1.02%)
DIA : 422.30 (+1.02%)
$IUXX : 20,227.46 (+1.32%)
QQQ : 492.21 (+1.28%)
ZNZ24 : 109-160 (-0.82%)
MU : 105.49 (+3.70%)
QCOM : 165.91 (+0.44%)
LZB : 39.55 (+2.09%)
CLDX : 25.43 (+0.16%)
KR : 57.39 (+1.99%)
Celldex: Q1 Earnings Snapshot

Celldex: Q1 Earnings Snapshot

CLDX : 25.43 (+0.16%)
Celldex: Q4 Earnings Snapshot

Celldex: Q4 Earnings Snapshot

CLDX : 25.43 (+0.16%)
Why Celldex Therapeutics Blasted 13% Higher on Monday

The biotech's CSU treatment advanced in the laboratory.

CLDX : 25.43 (+0.16%)
Freshpet, Celldex Therapeutics rise; TreeHouse Foods, Dish Network fall, Monday, 11/6/2023

Stocks that traded heavily or had substantial price changes on Monday: Freshpet, Celldex Therapeutics rise; TreeHouse Foods, Dish Network fall

CLDX : 25.43 (+0.16%)
THS : 37.06 (-1.23%)
HGV : 37.67 (+0.37%)
DISH : 5.77 (+1.94%)
FRPT : 151.59 (+0.68%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

CELLDEX THERAPEUTICS is an integrated biopharmaceutical company that applies its comprehensive Precision Targeted Immunotherapy Platform to generate a pipeline of candidates to treat cancer and other difficult-to-treat diseases. Celldex's immunotherapy platform includes a complementary portfolio of monoclonal...

See More

Key Turning Points

3rd Resistance Point 27.24
2nd Resistance Point 26.48
1st Resistance Point 25.95
Last Price 25.43
1st Support Level 24.67
2nd Support Level 23.91
3rd Support Level 23.38

See More

52-Week High 53.18
Fibonacci 61.8% 42.20
Fibonacci 50% 38.81
Fibonacci 38.2% 35.41
Last Price 25.43
52-Week Low 24.43

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar